Hologic Stock

Hologic EBIT

The EBIT of Hologic (HOLX) as of Jun 27, 2026 is 1.07 TT USD.In the previous year, EBIT was 970.2 T USD — a change of 10.14% (higher).

EBIT

1.07 TTUSD

YoY

10.14%

Last updated:

In 2026, Hologic's EBIT was 1.07 TT USD, a 10.14% increase from the 970.2 T USD EBIT recorded in the previous year.

The Hologic EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT (B USD)
Date
EBIT (B USD)
Jan 1, 2006
0.07 base
Jan 1, 2007
0.15 base
Jan 1, 2008
0.38 base
Jan 1, 2009
0.32 base
Jan 1, 2010
0.18 base
Jan 1, 2011
0.28 base
Jan 1, 2012
0.16 base
Jan 1, 2013
0.2 base
Jan 1, 2014
0.36 base
Jan 1, 2015
0.48 base
Jan 1, 2016
0.56 base
Jan 1, 2017
0.48 base
Jan 1, 2018
0.51 base
Jan 1, 2019
0.57 base
Jan 1, 2020
1.15 base
YEAREBIT (B USD)
2031 est -
2030 est -
2029 est 1.59
2028 est 1.38
2027 est 1.33
2026 est 1.27
2025 1.07
2024 0.97
2023 0.94
2022 1.65
2021 2.48
2020 1.15
2019 0.57
2018 0.51
2017 0.48
2016 0.56
2015 0.48
2014 0.36
2013 0.2
2012 0.16
2011 0.28
2010 0.18
2009 0.32
2008 0.38
2007 0.15
2006 0.07
Access this data via the Eulerpool API

Hologic Revenue

Hologic Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2006
462.7 M USD
65.1 M USD
27.4 M USD
Jan 1, 2007
738.4 M USD
147.8 M USD
94.6 M USD
Jan 1, 2008
1.67 B USD
377 M USD
-415.6 M USD
Jan 1, 2009
1.64 B USD
324.1 M USD
-2.22 B USD
Jan 1, 2010
1.68 B USD
181.7 M USD
-62.8 M USD
Jan 1, 2011
1.79 B USD
281.9 M USD
157.2 M USD
Jan 1, 2012
2 B USD
163.1 M USD
-73.6 M USD
Jan 1, 2013
2.49 B USD
203.1 M USD
-1.17 B USD
Jan 1, 2014
2.53 B USD
363.6 M USD
17.3 M USD
Jan 1, 2015
2.71 B USD
483.6 M USD
131.6 M USD
Jan 1, 2016
2.83 B USD
559.1 M USD
330.8 M USD
Jan 1, 2017
3.06 B USD
483.8 M USD
755.5 M USD
Jan 1, 2018
3.22 B USD
508 M USD
-111.3 M USD
Jan 1, 2019
3.37 B USD
568.2 M USD
-203.6 M USD
Jan 1, 2020
3.78 B USD
1.15 B USD
1.12 B USD

Hologic Margins

Hologic stock margins

The Hologic margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Hologic. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Hologic.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2006
41.78 %
14.07 %
5.92 %
Jan 1, 2007
46.76 %
20.02 %
12.81 %
Jan 1, 2008
53.3 %
22.51 %
-24.82 %
Jan 1, 2009
52.38 %
19.8 %
-135.4 %
Jan 1, 2010
43.86 %
10.82 %
-3.74 %
Jan 1, 2011
51.6 %
15.75 %
8.79 %
Jan 1, 2012
49.66 %
8.14 %
-3.68 %
Jan 1, 2013
46.67 %
8.15 %
-47.06 %
Jan 1, 2014
50.27 %
14.37 %
0.68 %
Jan 1, 2015
52.96 %
17.88 %
4.87 %
Jan 1, 2016
55.19 %
19.74 %
11.68 %
Jan 1, 2017
52.99 %
15.82 %
24.7 %
Jan 1, 2018
52.73 %
15.79 %
-3.46 %
Jan 1, 2019
51.96 %
16.87 %
-6.05 %
Jan 1, 2020
59.67 %
30.47 %
29.53 %

Hologic Stock analysis

What does Hologic do? Hologic Inc. is a company from the United States that has established itself in the medical technology market. The company was founded in 1985 by Jay A. Stein, who set the goal of developing products and services that contribute to improving people's lives. Hologic specializes in artificial intelligence (AI) based diagnostic and therapeutic technology that increases the safety, effectiveness, and accuracy of medical procedures. The company initially focused on products in the field of mammography, but has since expanded to various sectors including imaging, gynecology, skeletal, and surgery. Hologic offers its customers products such as tomosynthesis systems, robot-assisted surgery systems, image analysis software, and a variety of reagents, kits, and tests. The company's business model is focused on innovative technology and science, aiming to optimize medical interventions and thus reduce and improve healthcare costs. Hologic is dedicated to research and development and has already filed dozens of patents. In the field of breast cancer diagnostics, Hologic has developed various mammography systems that have broken the standard of mammography. Through the use of tomosynthesis, a 3D-based diagnostic, it is possible to detect tumors and malignant changes earlier. This procedure has been widely used by many doctors around the world and has proven to be a reliable method for early detection of breast cancer. In gynecology, Hologic specializes in the development of diagnostic tests for infectious agents and hormones. The tests, such as the Aptima HPV test, are fast, sensitive, and reliable. They help to detect infectious agents earlier and initiate appropriate therapy. Hologic Taurus, a robot-assisted surgery system, has been developed to enable minimally invasive interventions that can be used to treat uterine fibroids. This method allows for a drastic reduction in hospital stay duration and recovery time. In the field of skeletal, Hologic offers various systems that are helpful in the diagnosis and treatment of osteoporosis. The widely used DXA system (Dual-Energy X-Ray Absorptiometer) is still one of the most accurate devices for measuring bone density. Additionally, Hologic is an company that not only focuses on medical technology but also pursues the larger goal of improving people's lives. An example of this is their partnership with the organization Pink Ribbon, which serves as a global ambassador for breast cancer early detection. Hologic has developed a special mammography system called Pink Affirm. For every system sold, Hologic donates a certain amount to Pink Ribbon. Overall, Hologic Inc. has become an important player in the field of medical technology and diagnostics. Through its innovative technologies and products, the company contributes to improving the health and lives of people worldwide. Hologic is one of the most popular companies on Eulerpool.

EBIT Details

Analyzing Hologic's EBIT

Hologic's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of Hologic's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

Hologic's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in Hologic’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about Hologic stock

EBIT of Hologic amounted to 970.2 T USD 1.07 TT

The sales revenue is important for evaluating a stock.

EBIT is an acronym for "Earnings Before Interest and Tax" and represents a company's gross profit before taxes and interest are deducted. The EBIT amount is often used as a metric to evaluate a company.

History

The EBIT was originally introduced in the 1940s when the US Internal Revenue Service (IRS) passed a new tax law. This law required companies to calculate their profit before deducting taxes and interest on loans (or "interest and taxes"). Since then, the EBIT has been used as one of the key financial indicators in evaluating a company.

Usage

The EBIT can be used to assess a company by comparing its financial results to a benchmark or a comparative value. The EBIT is also used to determine how much the company's shareholders will receive from its operating income.

Calculation

EBIT is calculated by deducting taxes and interest on loans from the company's net profit. This amount can be calculated in various ways, but the most common method is as follows:

EBIT = Net profit + interest and taxes

Example: Eulerpool: Your source for quantitative stock data At Eulerpool, we are dedicated to providing you with comprehensive and accurate stock information. Our website offers a wide range of tools and features, including charts, stock lists, and more. Whether you are an experienced investor or just starting out, our platform is designed to meet your needs. With our in-depth analytics and algorithms, you can make informed decisions and stay ahead of the market. Explore our extensive collection of stocks, track their performance, and access real-time data. With Eulerpool, you can easily navigate the world of finance and monitor the stocks that matter to you. Join our community today and gain valuable insights into the world of stocks and investments. Sign up for free and discover the power of Eulerpool. Stay informed. Stay ahead. Eulerpool - your trusted partner in stock data.
Net profit of XYZ Co. = $1,000,000
Interest and taxes = $ 500,000
EBIT of XYZ Co. = $1,500,000

Application

The EBIT value is often used to determine and evaluate the financial stability of a company. The EBIT value can also be used to determine how much money a company can spend on investments or dividends.

Use of EBIT in stock investment

Investors use EBIT to determine if a stock is over- or undervalued. If a company has a high EBIT value, it may indicate that its stock is overvalued, as the profit it generates could be lower than what it would generate with a different stock.

Advantages of EBIT

EBIT is a helpful measure for determining the financial stability of a company. There are several advantages associated with using EBIT, such as:
- EBIT eliminates the impact of financing on the company's earnings.
- It is a useful measure for determining the profits that a company can distribute to its shareholders.
- It can be used to determine whether a stock is overvalued or undervalued.

Disadvantages of EBIT

There are also some disadvantages to using EBIT, such as:
- EBIT cannot be used as the sole measure to evaluate a company as it does not reflect the overall profit of the company.
- EBIT can be influenced by unforeseen events such as a tax increase.
- EBIT is not always a reliable indicator of a company's future profit development.

Conclusion

The EBIT is an important measure used to evaluate a company. It can be used to determine how much money a company can generate from its operational results and whether a stock is overvalued or undervalued. However, the EBIT also has some disadvantages as it does not reflect the overall profitability of a company and can be influenced by unforeseen events. Therefore, it is important to consider the EBIT in conjunction with other financial indicators to obtain a complete picture of the company.

Access this data via the Eulerpool API

Income Statement — Hologic

All Key Metrics — Hologic